ABCL

AbCellera Biologics, Inc

Halal Rating :
Comfortable
Last Price $2.77 Last updated:
Market Cap $754.35m
7D Change -11.5%
1 Year Change -49.17%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

AbCellera Biologics, Inc. is a technology company that searches, decodes, and analyzes natural immune systems to discover antibodies that can be developed to prevent and treat disease. The company's AI-powered drug discovery platform identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic.

The company partners with pharmaceutical companies to discover and develop antibody-based therapies, particularly focusing on infectious diseases, cancer, and autoimmune conditions.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $6.51m $100.17m - - 0.00% 0.00%
June 30, 2024 $7.32m $100.78m - - 0.00% 0.00%
March 31, 2024 $9.95m $64.85m - - 0.00% 0.00%

Company Impact

Help us evaluate AbCellera Biologics, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates